Notice on Convening the 2nd Extraordinary General Meeting in 2024
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Notice on Convening the 2nd Extraordinary General Meeting in 2024
Filed with SSE · · 5 pages · Chinese
Release
Jianmin Pharmaceutical Group Co Ltd. on 6ix
Earlier from Jianmin Pharmaceutical
- Announcement on Election of Director to Act as Chairman
- Announcement on Holding the Performance Briefing for Q3 2024
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
- Announcement on the Second Unlocking of Restricted Stock Involved in the 2022 Restricted Stock Incentive Plan
- Announcement on Obtaining the Drug Registration Certificate
Later from Jianmin Pharmaceutical
- Announcement on Inclusion and Renewal of the Company's Products on the Catalogue of Drugs for Basic National Medical Insurance (2024)
- Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
- Announcement on Resolution of the 30th Meeting of the 10th Board of Directors
- Announcement on External Donations
- Implementation Announcement on Providing Guarantee for Bank Credit Lines of Subsidiary
Follow Jianmin Pharmaceutical into a list and get an email when it puts out news.
Follow Jianmin Pharmaceutical